Open AccessAdvances in treating chronic lymphocytic leukemia
Author(s) -
Eugen Tausch,
Daniel Mertens,
Stephan Stilgenbauer
Publication year - 2014
Publication title -
f1000prime reports
Language(s) - English
Resource type - Journals
ISSN - 2051-7599
DOI - 10.12703/p6-65
Subject(s) - chronic lymphocytic leukemia , medicine , leukemia , immunology , transplantation , intensive care medicine , oncology
Chronic lymphocytic leukemia (CLL) is the most prevalent type of leukemia, affects mostly elderly CLL patients, and is incurable without allogeneic transplantation. Although classic chemo(immuno)therapy is still the standard of care for patients in need of treatment, this paradigm might change in the near future with the advent of new therapeutic agents targeting major pathogenic pathways in CLL.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom